Printed from the IBC Life Sciences Web site on September 30, 2016 6:00 PM ET.
Page location: http://www.ibclifesciences.com/25520.xml
Matthew Stober had a dramatic story to tell when he came through San Diego to speak to pharma manufacturing executives at last month's annual Vaccine Production Summit. As the global head of technical operations for Cambridge, MA-based Novartis Vaccines & Diagnostics, Stober was closely involved in the corporate turnaround that enabled Novartis to ship more than 150 million doses of H1N1 flu vaccine to more than 20 countries during last year's global pandemic.
How Novartis Vaccines & Diagnostics Turned Around the Ship it Got From Chiron
Read the rest of the article on the Xconomy Web site